No headlines found.
No press releases found.
No news found.
AllianzIM U.S. Equity Buffer10 Nov ETF seeks to match, at the end of the current Outcome Period, the share price returns of the SPDR S&P 500 ETF Trust (the "Underlying ETF"), up to a specified upside Cap, while providing a Buffer against the first 10% of Underlying ETF losses. The Cap and the Buffer will be reduced after taking into account management fees and other Fund fees and expenses. The current Outcome Period is from November 1, 2025 to October 31, 2026. Under normal market conditions, the Fund invests at least 80% of its net assets in instruments with economic characteristics similar to U.S. large cap equity securities. Specifically, the Fund intends to invest substantially all of its assets in FLexible EXchange Options ("FLEX Options") that reference the Underlying ETF. FLEX Options are customized equity or index options contracts that trade on an exchange, but provide investors with the ability to customize key contract.
Allianzim U.S. Equity Buffer10 Nov ETF trades on the ARCA stock market under the symbol NVBT.
As of July 1, 2026, NVBT stock price declined to $39.56 with 381 million shares trading.
NVBT has a market cap of $30.66 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, NVBT traded as high as $39.76 and as low as $26.50.
NVBT has underperformed the market in the last year with a return of +15.2%, while the SPY ETF gained +21.9%. In the last 3 month period, NVBT fell short of the market, returning +12.9%, while SPY returned +18.3%. However, in the most recent 2 weeks NVBT has outperformed the stock market by returning -0.1%, while SPY returned -0.4%.
NVBT support price is $39.40 and resistance is $39.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVBT shares will trade within this expected range on the day.
